Table 5 |
||||
|
Post-treatment changes in lymphocytes |
||||
| Post-treatment percentage change from baseline (mean ± SD) |
||||
|
|
||||
| Parameter |
6 weeks |
10 weeks |
18 weeks |
32 weeks |
|
|
||||
| Lymphocytes |
n = 14 |
n = 12 |
n = 11 |
n = 7 |
| B cells |
-54%a ± 25% |
-45%a ± 47% |
-39%a ± 23% |
-31%a ± 33% |
| T cells |
2% ± 36% |
-6% ± 34% |
1% ± 13% |
-5% ± 19% |
|
|
||||
|
aDenotes statistical significance of the observed median change-from-baseline value with P ≤ 0.05 by Wilcoxon signed rank test. None of the changes from baseline in T cells was statistically significant. SD, standard deviation. |
||||
|
Steinfeld et al. Arthritis Research & Therapy 2006 8:R129 doi:10.1186/ar2018 |
||||
